Blue Stream Laboratories Doubles Capacity in Woburn

Blue Stream Laboratories, a company whose clients range from small start-ups and virtual biotechs to Fortune 500 pharmaceutical and medical device companies, has completed a move into larger space in Woburn.

The new Woburn location, 8 Henshaw St., is double the size of its former Cambridge facility. The company expects to increase its staffing by 30 percent over the next year to accommodate continued growth.

“We continue to add new clients each month, especially among mid- and large-biotech companies, both in the U.S. and in Asia,” wrote Michael Kouchakdjian, president of Blue Stream, in a news release. “This growth puts Blue Stream on pace for more than a 50 percent increase in revenue over 2013.”

Over the past year, Blue Stream experienced double-digit growth due to its biophysical characterization services, mass spectrometry laboratory, and comprehensive biosimilars support programs.

Founded in 2006, Blue Stream supports and enhances its clients’ innovation through the lab’s deep expertise in product characterization, cGMP lot release, and stability program support.

Blue Stream is benefiting from an industry-wide increase in outsourcing, and a review and approval process for biosimilars for small molecule generic drugs, according to company officials.

According to research firm Frost & Sullivan, the global market for biosimilars will grow to $23 billion in five years, up substantially from $1.2 billion in 2013.

.

.